ProstaLund AB (publ) develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) in Sweden and internationally. The company also offers CoreTherm, a heat treatment of BPH; and Gepan instill for the treatment of chronic bladder inflammation. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Análisis de IA de PROSTALUND AB
Haz clic en cualquier análisis a continuación para obtener información instantánea de la IA de finAgent
Últimos análisis de IA sobre PROSTALUND AB
Aún no hay hilos de IA disponibles para esta empresa.